HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders.

Abstract
Sodium phenylbutyrate (NaPBA) is a commonly used medication for the treatment of patients with urea cycle disorders (UCDs). Previous reports involving small numbers of patients with UCDs have shown that NaPBA treatment can result in lower plasma levels of the branched-chain amino acids (BCAA) but this has not been studied systematically. From a large cohort of patients (n=553) with UCDs enrolled in the Longitudinal Study of Urea Cycle Disorders, a collaborative multicenter study of the Urea Cycle Disorders Consortium, we evaluated whether treatment with NaPBA leads to a decrease in plasma BCAA levels. Our analysis shows that NaPBA use independently affects the plasma BCAA levels even after accounting for multiple confounding covariates. Moreover, NaPBA use increases the risk for BCAA deficiency. This effect of NaPBA seems specific to plasma BCAA levels, as levels of other essential amino acids are not altered by its use. Our study, in an unselected population of UCD subjects, is the largest to analyze the effects of NaPBA on BCAA metabolism and potentially has significant clinical implications. Our results indicate that plasma BCAA levels should to be monitored in patients treated with NaPBA since patients taking the medication are at increased risk for BCAA deficiency. On a broader scale, these findings could open avenues to explore NaPBA as a therapy in maple syrup urine disease and other common complex disorders with dysregulation of BCAA metabolism.
AuthorsLindsay C Burrage, Mahim Jain, Laura Gandolfo, Brendan H Lee, Members of the Urea Cycle Disorders Consortium, Sandesh C S Nagamani
JournalMolecular genetics and metabolism (Mol Genet Metab) 2014 Sep-Oct Vol. 113 Issue 1-2 Pg. 131-5 ISSN: 1096-7206 [Electronic] United States
PMID25042691 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Amino Acids, Branched-Chain
  • Amino Acids, Essential
  • Phenylbutyrates
Topics
  • Adolescent
  • Adult
  • Aged
  • Amino Acids, Branched-Chain (blood, deficiency)
  • Amino Acids, Essential (blood)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Hyperammonemia (etiology)
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Phenylbutyrates (administration & dosage, adverse effects, therapeutic use)
  • Urea Cycle Disorders, Inborn (blood, diagnosis, drug therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: